14h
TipRanks on MSNModerna’s 2024 Struggles: Navigating Commercial Challenges and Market Competition in the Vaccine IndustryModerna (MRNA) has disclosed a new risk, in the Sales & Marketing category. Moderna faces significant commercial challenges, particularly in ...
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...
Bullish option flow detected in Moderna (MRNA) with 76,253 calls trading, 1.4x expected, and implied vol increasing almost 8 points to 77.82%.
While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...
Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...
Word of mouth and enterprise consumers are helping OpenAI grow its weekly user base quickly amid heavy competition.
Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...
The Montana House of Representatives on Wednesday voted overwhelmingly against House Bill 371, a measure that would have banned mRNA vaccines — used primarily in COVID-19 vaccines and booster shots — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results